GlaxoSmithKline to Access Concert’s Deuterium Technology
By Taskin Ahmed
PharmaDeals Review: Vol 2009 Issue 6 (Table of Contents)
Published: 18 Jun-2009
DOI: 10.3833/pdr.v2009i6.1124 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Concert Pharmaceuticals and GlaxoSmithKline (GSK) are to collaborate on the development of deuterium-containing drugs, including CTP-518, a deuterated version of Bristol-Myers Squibb’s HIV protease inhibitor, atazanavir...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
RSS